GT
ZSPH

Glenmede Trust’s ZS PHARMA INC COMS TK (DE) ZSPH Stock Holding History

Glenmede Trust’s Portfolio ZSPH Stock Details ZSPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-113
Closed -$5K – 2938
2015
Q2 		$5K Hold
113
– – ﹤0.01% 2259
2015
Q1 		$4K Hold
113
– – ﹤0.01% 2307
2014
Q4 		$4K Buy
+113
New +$4.46K ﹤0.01% 2355

Other funds holding ZSPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DPA
Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Glenmede Trust's ZSPH Position: Q3 2015 in Review

Glenmede Trust sold out of ZS PHARMA INC COMS TK (DE) (ZSPH) in Q3 2015, closing a stake of 113 shares — an estimated $5K sold.

Glenmede Trust first reported a position in ZSPH in Q4 2014 and held it in 3 quarters. The position peaked at $5K in Q2 2015. 124 funds tracked by Wall St. Rank hold ZSPH as of Q3 2015.

  • Glenmede Trust reported no remaining ZS PHARMA INC COMS TK (DE) position as of Q3 2015 after selling out during the quarter.
  • Glenmede Trust sold 113 ZS PHARMA INC COMS TK (DE) shares in Q3 2015, an estimated $5K.
  • Glenmede Trust first reported a position in ZS PHARMA INC COMS TK (DE) in Q4 2014 and held it in 3 quarters.
  • Glenmede Trust's ZS PHARMA INC COMS TK (DE) position peaked at $5K in Q2 2015.
  • 124 funds tracked by Wall St. Rank held ZS PHARMA INC COMS TK (DE) as of Q3 2015.

Based on Glenmede Trust's 13F filing for Q3 2015, filed 12 Nov 2015.